Continue reading this on our app for a better experience

Open in App
Home Capital Broker's Calls

Citing 'gradual' recovery, CGS-CIMB maintains 'reduce' call on Grand Venture Technology

The Edge Singapore
The Edge Singapore • 2 min read
Citing 'gradual' recovery, CGS-CIMB maintains 'reduce' call on Grand Venture Technology
Photo: Albert Chua
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

William Tng of CGS-CIMB, in his Sept 26 note, has reiterated his 'reduce' call on Grand Venture Technology JLB

, given limited visibility of an early recovery to be enjoyed by the electronics manufacturing industry.

GVT reiterates that the industry remains affected by geopolitical tensions and weakness in the global economy.

"The semiconductor recovery could be gradual and the pace of orders from new front-end customers could be slow in FY2024," says Tng.

Nonetheless, GVT is optimistic that there are some signs of easing of excess inventory and expects order momentum to pick up towards the year end and into the coming FY2024, says Tng.

In addition, GVT maintains that the mid- and long-term outlook of the semiconductor industry is strong, led by growing investment in AI and its applications.

"Hence, GVT continues to grow its capabilities, expand production capacity, and enhance its service offerings to be ready for the next industry uptick," says Tng, adding that the company is making progress to bring on board frontend
semiconductor customers in the metrology, inspection, etch, and wafer deposition segments of the semiconductor industry. 

See also: DBS says S’pore T-bill holders are a ‘liquidity catalyst’ for S-REITs like Lendlease REIT, Keppel REIT

A new plant dedicated for front-end customers is on track to be ready by the end of the year and production equipment has been installed.

Meanwhile, GVT sees "stable" orders for its other businesses such as life sciences, medical, electronics, and aerospace.

However, Tng prefers to maintain his "reduce" call on the stock, along with a target price of 51 cents. He notes that GVT now trades at 12.5x FY2024 earnings while he values the stock at 11.3x earnings, which is 0.5 standard deviations below its 3-year average given limited visibility of an early recovery. 

See also: Handle duplicate Breaking news pushes

Tng warns that possible de-rating catalysts might include a severe drop in customer orders if the world slips into a recession and higher-than-expected spending for long-term growth. 

Upside risks, on the other hand, will be potential new customer wins with significant purchase orders and accretive M&As, resulting in better earnings and quicker-than-expected return of customer demand.

Highlights

New IHH Healthcare CEO Nair lays out growth plans
Company in the news

New IHH Healthcare CEO Nair lays out growth plans

Get the latest news updates in your mailbox
Never miss out on important financial news and get daily updates today
×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.